Plethico Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on June 01, 2013, has decided in-principle to issue bonus shares to the shareholders other than promoters /promoter group shareholders in the ratio of 1 Share for every 5 Shares held by them subject to necessary approval of SEBI for waiver of certain condition stipulated under SEBI ICDR Regulations and/or extension of time to comply with the Minimum Public Shareholding (MPS) requirements. The Issue of Bonus share will be implemented only on receipt of approval from SEBI.
The above information is a part of company’s filings submitted to BSE.
